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Diagnosis of pneumonia should be considered in any child with acute 
respiratory symptoms, including cough, fast breathing or difficulty 
breathing. Diagnostic modalities include clinical, radiographic and 
aetiological evaluation to: (i) establish whether pneumonia is present; 
(ii) assess severity of pneumonia; (iii) detect complications; and 
(iv) determine causative organism/s. In general, investigations to 
determine the cause of pneumonia are indicated only in children who 
require hospitalisation.
Clinical evaluation
The main symptoms of pneumonia are cough, difficulty breathing 
or tachypnoea. Physical examination should include: assessment of 
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Results. Diagnosis of pneumonia should be considered in a child with acute cough, fast breathing or difficulty breathing. Revised World 
Health Organization guidelines classify such children into: (i) severe pneumonia; (ii) pneumonia (tachypoea or lower chest indrawing); 
or (iii) no pneumonia. Malnourished or immunocompromised children with lower chest indrawing should be managed as cases of 
severe pneumonia. Pulse oximetry should be done, with hospital referral for oxygen saturation <92%. A chest X-ray is indicated in severe 
pneumonia or when tuberculosis (TB) is suspected. Microbiological investigations are recommended in hospitalised patients or in outbreak 
settings. Improved aetiological methods show the importance of co-infections. Blood cultures have a low sensitivity (<5%), for diagnosing 
bacterial pneumonia. Highly sensitive, multiplex tests on upper respiratory samples or sputum detect multiple potential pathogens in 
most children. However, even in symptomatic children, it may be impossible to distinguish colonising from causative organisms, unless 
identification of the organism is strongly associated with attribution to causality, e.g. respiratory syncytial virus, Mycobacterium tuberculosis, 
Bordetella pertussis, influenza, para-influenza or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Investigations for TB 
should be considered in children with severe pneumonia who have been hospitalised, in a case of a known TB contact, if the tuberculin skin 
test is positive, if a child is malnourished or has lost weight, and in children living with HIV. Induced sputum may provide a higher yield 
than upper respiratory sampling for B. pertussis, M. tuberculosis and Pneumocystis jirovecii.
Conclusions. Advances in clinical, radiological and aetiological methods have improved the diagnosis of childhood pneumonia.
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the child’s general appearance, measurement of respiratory rate, 
evaluation of the work of breathing and doing pulse oximetry. 
Auscultation of the chest should be done where possible (evidence 
level II); however, there is wide inter- and intra-observer variability 
in the interpretation of auscultatory sounds in paediatric 
pneumonia.[1] 
The World Health Organization (WHO) guidelines classify 
children with cough or difficulty breathing into three categories, 
based on clinical signs – severe pneumonia, pneumonia or no 
pneumonia (evidence level Ia) (Fig. 1; Table 1).[2] Children with 
lower chest indrawing are now classified as having pneumonia, 
rather than severe pneumonia. Treatment is based on these 
categories – severe pneumonia requires referral to hospital and 
administering antibiotics; pneumonia requires oral antibiotics 
and outpatient management with follow-up; and no pneumonia 
is treated symptomatically. However, children living with HIV 
(CLWH), malnourished children or immunocompromised children 
who present with lower chest indrawing, should be regarded as 
having severe pneumonia and referred to hospital for appropriate 
management (evidence level Ib). 
Assessment of severity
Assessment of the general appearance of the child is helpful to 
evaluate severity of illness. Any child with a general danger sign 
requires referral to hospital. All children <2 months of age with signs 
of pneumonia require hospital admission (Table 2).
Excessive work of breathing, as indicated by grunting, nasal flaring 
or very severe chest wall indrawing, is a useful indicator of severity 
(evidence level Ia).[3,4] British Thoracic Society (BTS) guidelines 
recommend that signs indicating excessive work of breathing are 
more specific for diagnosing severe pneumonia than respiratory rate 
(evidence level II).[5]
Assessment of oxygenation is important as a measure of severity 
(evidence level Ia).[6] Pulse oximetry should be performed in all 
children, using a paediatric wrap-around probe (evidence level Ib). A 
saturation of <92% or <90% at higher altitudes (≥1 800 m) indicates 
Children aged 2 - 59 months, 
with cough and/or 
diculty breathing
Give rst dose of antibiotic and refer to facility for
injectable antibiotic/supportive therapy
Cough and cold
   No pneumonia
Fast breathing and/or chest indrawing 
   Pneumonia
General danger sign
   Severe pneumonia or severe disease
Home care, with follow-up if symptoms worsen or 
fail to resolve
Oral amoxicillin and home care, with close follow-up
Fig. 1. Revised World Health Organization classification and treatment of childhood pneumonia at health facilities.[2]
Table 1. Categories of pneumonia – World Health Organization classification[2]
Category Characteristics






Oxygen saturation <90% (at altitude >1 800 m) or <92% or central cyanosis 
or
Severe respiratory distress (grunting, very severe chest indrawing)
Infant <2 months of age with 
A general danger sign 
or
Chest wall indrawing 
or 
Tachypnoea (≥60 breaths per min)
Children living with HIV, immune-compromised or malnourished children with
Lower chest indrawing
Pneumonia Child >2 months of age with 
Lower chest indrawing 
or 
Tachypnoea
≥50 breaths per min for infants 2 - 11 months of age 
≥40 breaths per min for children 1 - 5 years of age
No pneumonia No signs of pneumonia or severe pneumonia, i.e. upper respiratory tract infection
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the need for hospital admission and supplemental oxygen (evidence 
level Ia).[5,7] 
Radiological diagnosis
A chest X-ray (CXR) may be useful for confirming the presence of 
pneumonia or complications such as a lung abscess or empyema 
(Table 3). A CXR cannot accurately discriminate between viral and 
bacterial pneumonia (evidence level II).[5,7,8] Overall, undertaking 
a CXR does not influence outcome and rarely informs changes of 
treatment in the ambulatory setting (evidence level Ib).[8] There is 
also no evidence that a lateral CXR improves the diagnostic yield in 
children with pneumonia,[9] except for detection of hilar adenopathy 
if tuberculosis (TB) is suspected (evidence level II).[10,11]
The use of a CXR has several limitations, including radiographic 
features being masked by anatomical structures; a normal CXR in 
the early stages of pneumonia; and lack of inter-reader agreement 
in interpretation.[12] Clinician-led point-of-care ultrasound is 
increasingly being used, with higher inter-observer agreement than 
for a CXR (evidence level Ib).[12,13] Evidence suggests a similar or 
higher yield in the diagnosis of consolidation or pleural effusion 
when using ultrasound (evidence level Ib). However, ultrasound is 
not yet routinely available for the diagnosis of pneumonia, and a CXR 
remains the standard investigation.[12] 
Computed tomography (CT) is not recommended as a first-
line diagnostic tool, but where available, can be considered for 
detecting complications of pneumonia in the acute or subacute 
phase (for diagnosing a suppurative complication such as necrotising 
pneumonia, abscess or empyema) and in the chronic phase (for 
diagnosing bronchopleural fistula or detecting and localising 
bronchiectasis); it can also be useful for differentiating pneumonia 
from other pathological conditions, including endobronchial lesions/
foreign bodies causing atelectasis and for demonstrating previously 
undiagnosed, underlying congenital lesions.[5,7] Radiation dose is less 
of a concern, as low-dose scans (at doses of ~10 CXRs or 3 - 5 antero-
posterior and lateral CXRs) can be performed.
Follow-up chest X-ray
A follow-up CXR after acute uncomplicated pneumonia is not 
indicated if there is clinical improvement (evidence level II).[7,16] A 
follow-up CXR at 2 - 4 weeks should be done: (i) in children with 
lobar collapse; (ii) to document resolution of a round pneumonia 
(as this may mimic the appearance of a Ghon focus); and (iii) in 
those with ongoing respiratory symptoms.[5,7] A chest ultrasound 
scan should be considered as an alternative to a repeat CXR in 
children with unresolving or worsening signs and symptoms to detect 
complications such as pleural effusion (evidence level Ib).[13,17,18]
Aetiological diagnosis
Clinical assessment and chest radiography cannot determine the 
aetiology of pneumonia.[5,19-21] Diffuse bilateral wheezing is, however, 
often associated with a viral infection, especially respiratory syncytial 
virus (RSV) (evidence level Ib).[20] Various diagnostic modalities are 
available for aetiological diagnosis, such as microscopy, molecular 
diagnostics, culture and antigen detection (Table 4). Recent advances 
in understanding the aetiology have highlighted that pneumonia 
may be due to interactions or co-infection with several organisms, 
including viral-viral and viral-bacterial infections.[7,22] Testing of 
upper respiratory samples may not, however, discriminate between 
colonising and pathogenic organisms, making it difficult to attribute 
aetiology. Identification of organisms such as Bordetella pertussis, 
RSV, influenza virus, para-influenza virus, severe acute respiratory 
syndrome coronavirus 2 (SARS-CoV-2) or Mycobacterium tuberculosis 
in upper respiratory samples among symptomatic children is, 
however, strongly attributable to the aetiology of lower respiratory 
tract infection (evidence level Ia).[23,24] 
The following should be considered when investigating the 
aetiology:
• General tests for infection, including acute-phase reactants 
(erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), 
white cell count (WCC), neutrophil count and procalcitonin 
(PCT)) do not reliably differentiate bacterial from viral pneumonia 
and should not be routinely used (evidence level Ib).[7,25] CRP 
concentrations ≥40 mg/L with radiological confirmation of 
pneumonia may suggest bacterial pneumonia (evidence level II).[26]
• HIV status should be determined in all children requiring hospital 
admission for pneumonia. 
• Microbiological investigations on blood, pleural fluid or respiratory 
samples should only be done in children requiring hospital 
admission, i.e. in those with severe disease or complications, or in 
outbreak situations (evidence level IVa).[5,7] 
• For detection of viruses, polymerase chain reaction (PCR) and/or 
immunofluorescence on nasal samples may be useful (evidence 
level Ib). Viruses strongly associated with pneumonia include 
RSV, influenza and para-influenza virus. Detection of adenovirus, 
human metapneumovirus (HMPV) or rhinovirus, even though 
associated with pneumonia, should be interpreted with caution, 
as healthy children or those with upper respiratory tract infection 
may have a positive test (evidence level Ia).[22,27] Testing for SARS-
CoV-2 using PCR can be done on mid-turbinate nasal swabs.
• Blood culture has a very low diagnostic yield. Antibiotic pre-
exposure and specimen volume impact on blood culture yield.[28] 
Overall, ~5% of blood cultures of suspected bacterial pneumonia 
Table 2. Indications for hospital admission
All children <2 months of age
Children >2 months of age with
A general danger sign 
Grunting, severe lower chest indrawing
Stridor in a calm child 
 Room air arterial oxygen saturation <92% at sea level or  
<90% at high altitude, or central cyanosis
Severe malnutrition
HIV-infected, immune-compromised or malnourished child with 
lower chest indrawing
Family unable to provide appropriate care
Table 3. Indications for chest X-ray (evidence level Ib)
• Severe pneumonia 
• Suspected pulmonary tuberculosis 
• Suspected foreign body aspiration
• Pneumonia unresponsive to standard management
• Consider in children <5 years of age, presenting with fever (>39°C), leukocytosis and no obvious source of infection, as ~18% of such patients 
have radiographic pneumonia (evidence level III)[14,15]
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Table 4. Summary of investigations in children hospitalised for pneumonia[12]
Advantages Disadvantages
Vital signs
Pulse oximetry Accurate measure of hypoxaemia; guides the use  
of supplemental oxygen 
-
Radiological tests
Chest X-ray Assess extent of pneumonia 
Detect complications
Unable to distinguish aetiology
Poor intra- and inter-observer 
agreement for interpretation of some 
features
Lung ultrasound Higher inter- and intrapersonal agreement of 
radiological findings compared with CXR
May be more sensitive than CXR for detecting 
abnormalities
Easily repeatable, no radiation
Can be done by non-radiologists with minimal training
Not widely available 
Few clinicians have expertise in its use 
Blood
Culture for bacterial pathogens Relative ease of collection
Positive culture with a clinically significant pathogen 
has high specificity 
Able to guide empirical antibiotic susceptibility 
patterns
Low sensitivity; therefore, high cost per 
case detected
Molecular testing More sensitive than blood culture for some targets,  
e.g. pneumococcal lytA
Useful for CMV viral load
Lacks specificity for disease, e.g. lytA 
detection may reflect pneumococcal 
carriage
Serology Useful for epidemiological studies and for specific 
pathogens, e.g. B. pertussis
Usually requires acute and convalescent 
sera; therefore, not useful for guiding 
acute treatment decisions
Biomarker detection Potential to discriminate bacterial v. viral infection Accuracy for distinguishing bacterial 
v. viral pneumonia is suboptimal for 
available biomarkers (CRP, ESR  
and PCT)
HIV infection HIV testing essential in hospitalised children whose 
HIV status is unknown
HIV infection or HIV exposure may impact on 
the spectrum of pathogens considered in empirical 
antibiotic therapy
-
Nasopharyngeal or nasal swab or aspirate
 Bacterial culture, molecular or antigen 
detection of bacteria and viruses
Ease of collection, relatively good correlation of results 
with sputum testing, method of choice for some viruses 
(e.g. RSV, influenza, para-influenza virus, SARS-
CoV-2), bacteria (B. pertussis) and P. jirovecii
Colonisation or infection of the upper 
airway does not imply that organisms 
are causing pneumonia 
Predictive value of attributing causality 
is high for RSV, influenza virus, para-
influenza virus 3 and M. tuberculosis
Limited value for most other bacteria 
and viruses 
Sputum (expectorated or induced)
 Bacterial culture, molecular or antigen 
detection of bacteria (M. tuberculosis,  
B. pertussis) or P. jirovecii
Relative ease of collection
Incremental yield over testing of upper respiratory 
samples for M. tuberculosis, B. pertussis and P. jirovecii
Requires expertise, and should be 
conducted in a dedicated space that is 
well ventilated
May also detect organisms colonising or 
infecting upper airway
Urine antigen testing
Antigen detection Relative ease of collection Poor specificity for pneumococcal 
disease in children due to high 
prevalence of nasopharyngeal carriage
Continued ...
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cases are positive; the yield is higher in severe pneumonia[29,30] and 
in CLWH.[31]
• Induced sputum may provide a higher yield than upper 
respiratory secretions for B. pertussis, Pneumocystis jirovecii and 
M. tuberculosis.[32-36]
• Pulmonary TB should be considered in a child presenting with 
pneumonia or severe pneumonia, in a case of a known TB contact, 
if the tuberculin skin test is positive, if the child is malnourished 
or has lost weight, and in CLWH or in those who are HIV-exposed 
(evidence level 1b).[37-39] Two sequential respiratory samples, 
preferably expectorated or induced sputum, should be tested with 
Xpert MTB/RIF Ultra (Cepheid, USA) and mycobacterial culture 
(evidence level Ib).[40] 
• Pleural fluid can be tested for microscopy, culture, pneumococcal 
antigen (by latex agglutination), PCR for bacteria, mycobacterial 
culture and Xpert MTB/RIF Ultra (evidence level II).
Summary: Diagnosis 
1.  A diagnosis of pneumonia should be considered in any child who 
has an acute onset of cough, fast breathing or difficulty breathing.
2.  Revised WHO guidelines classify children with cough or difficulty 
breathing into: (i) severe pneumonia; (ii) pneumonia; and (iii) no 
pneumonia. Malnourished or immunocompromised children with 
lower chest indrawing should be managed as severe pneumonia 
(evidence level Ib).
3.  Excessive work of breathing, as indicated by grunting, nasal flaring 
or severe chest wall indrawing, is an important indicator of severity 
(evidence level Ia).
4.  Pulse oximetry should be performed on all children, with referral 
to hospital for oxygen if saturation is <92% or <90% at an alti -
tude >1 800 m (evidence level Ia).
5.  A CXR should not be done routinely (evidence level Ib), but should 
be performed in severe cases to confirm pneumonia and detect 
complications or when TB is suspected. 
6.  A follow-up CXR should only be done if the condition of a child 
does not improve or complications are suspected (evidence level II).
7.  Evidence for point-of-care chest ultrasound for diagnosis is 
accumulating. A chest ultrasound scan, rather than a repeat 
CXR, should be considered in children with ongoing symptoms 
(evidence level II).
8.  CRP ≥40 mg/L with radiological confirmation of pneumonia is 
supportive of a bacterial aetiology (evidence level II). 
9.  Microbiological investigations should not be performed routinely 
on children, but only in those requiring hospitalisation or in 
outbreak settings (evidence level IVa).
10.  Testing of nasal samples with PCR is useful for detecting RSV, 
influenza virus, para-influenza virus or SARS-CoV-2; other viruses 
should be cautiously interpreted, as healthy children or those with 
upper respiratory tract infection may have a positive test. 
11.  Induced sputum may provide a higher yield than upper respiratory 
samples for B. pertussis, P. jirovecii and M. tuberculosis.
12.  Investigations for TB should be done in children with pneumonia or 
severe pneumonia, a history of a TB contact, a positive tuberculin 
skin test, loss of weight or malnutrition or if HIV-infected.
Impact of HIV infection on clinical 
diagnosis of pneumonia
Clinical signs of pneumonia are similar in CLWH and HIV-
unin fected children; however, CLWH who are not on 
antiretroviral therapy (ART) are more likely to present with 
severe disease and have higher rates of treatment failure 
than immune-competent children (evidence level Ib).[41,42] 
Pneumonia resulting from opportunistic pathogens, such as 
P. jirovecii and cytomegalovirus (CMV), should be considered 
in infants living with HIV, and when pneumonia is a presenting 
feature of HIV or a child is not receiving ART.[41,42] 
Impact of HIV on radiological diagnosis
The interpretation of CXR changes is more difficult in HIV-infected 
children, as chronic radiological lung changes are common, especially 
with increasing age.[43] Increased bronchovascular markings, reticular 
densities, cavities, cysts and bronchiectasis are the most common 
chronic radiological changes.[44] Diffuse nodular densities and hilar 
or mediastinal adenopathy occurring in lymphocytic interstitial 
pneumonitis, may resemble TB.[44] Diffuse or scattered ground-glass 
opacification is a common manifestation of severe pneumocystis 
pneumonia (PCP) or CMV pneumonia, but no radiographic pattern 
is specific for either.[44] Bronchiolitis obliterans, characterised by 
fibrotic constriction or complete destruction of the bronchioles, 
should be considered in the differential diagnosis of multifocal 
consolidation and chronic hypoxia.[43] Perihilar airspace and 
reticular opacification, mainly in the lower lung zones, in addition 
to hilar lymphadenopathy and often large pleural effusion, are 
occasionally seen in CLWH with pulmonary manifestations of 
Kaposi sarcoma.[44]
Summary: HIV infection or exposure
Clinical signs of pneumonia are similar in HIV-infected and HIV-
uninfected children; however, the former are more likely to present 
with severe disease, have higher rates of treatment failure and 
Table 4. (continued) Summary of investigations in children hospitalised for pneumonia[12]
Advantages Disadvantages
Tracheal aspiration or bronchoalveolar lavage
 Bacterial culture, molecular or antigen 
detection of bacteria, P. jirovecii  
and viruses
More representative of organisms in the lower 
respiratory tract 
Less likely to be contaminated by upper respiratory 
tract flora
Few comparative studies v. other sample 
types 
Costly, invasive, requires expertise and 
patient intubation
Percutaneous lung aspiration
 Bacterial culture, molecular or antigen 
detection of bacteria and viruses
Most representative of lower respiratory tract, least 
contamination with upper airway respiratory tract flora
Useful mainly for peripheral infective 
foci in the right lung
Invasive, and requires expertise
Small risk of serious complications
CXR = chest X-ray; CMV = cytomegalovirus; B. pertussis = Bordetella pertussis; CRP = C-reactive protein; ESR = erythrocyte sedimentation rate; PCT = procalcitonin;  
RSV = respiratory syncytial virus; P. jirovecii = Pneumocystis jirovecii; M. tuberculosis = Mycobacterium tuberculosis.
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death and pneumonia with opportunistic infections than immune-
competent children (evidence level Ib).
Interpretation of CXR changes is more difficult in HIV-infected 
children, as chronic radiological lung changes are common, especially 
with longer survival (evidence level II).
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